» Articles » PMID: 37350980

Association Between Primary Hyperparathyroidism and Secondary Diabetes Mellitus: Findings From a Scoping Review

Overview
Journal Cureus
Date 2023 Jun 23
PMID 37350980
Authors
Affiliations
Soon will be listed here.
Abstract

An ill-defined association exists between diabetes mellitus (insulin resistance) and primary hyperparathyroidism. This article explores this phenomenon while providing an explanation for such a relationship and reviewing the evidence regarding the response to insulin sensitivity following a parathyroidectomy. Primary hyperparathyroidism may increase the risk of developing insulin resistance; peculiarly, this is not present in all patients. It is likely that both intracellular hypercalcemia and hypophosphatemia alter the insulin receptor expression and response; the contribution of parathyroid hormone is less clear. Following parathyroidectomy, patients may demonstrate improvement in their insulin sensitivity, while others have no response or a detrimental effect. A varied phenotype exists among patients, and furthermore, it is unclear why certain patients demonstrate improvement in insulin sensitivity following a parathyroidectomy, whereas others fail to do so. While this review provides a broad overview of the general endocrine community, it is imperative to note that clinical applicability is limited until further studies address these remaining uncertainties. Due to the lack of understanding regarding this endocrinological enigma, the presence of insulin resistance, at this present time, should not be a criterion for a parathyroidectomy.

Citing Articles

Inquiry of the Metabolic Traits in Relationship with Daily Magnesium Intake: Focus on Type 2 Diabetic Population.

Gheorghe A, Ciobica M, Nistor C, Gurzun M, Sandulescu B, Stanciu M Clin Pract. 2024; 14(4):1319-1347.

PMID: 39051301 PMC: 11270223. DOI: 10.3390/clinpract14040107.


Turning Points in Cross-Disciplinary Perspective of Primary Hyperparathyroidism and Pancreas Involvements: Hypercalcemia-Induced Pancreatitis, Gene-Related Tumors, and Insulin Resistance.

Carsote M, Nistor C, Gheorghe A, Sima O, Trandafir A, Nistor T Int J Mol Sci. 2024; 25(12).

PMID: 38928056 PMC: 11203827. DOI: 10.3390/ijms25126349.


Primary Hyperparathyroidism and Cardiovascular Disease: An Association Study Using Clinical Natural Language Processing Systems and Big Data Analytics.

Iglesias P, Arias J, Lopez G, Romero I, Diez J J Clin Med. 2023; 12(21).

PMID: 37959184 PMC: 10650925. DOI: 10.3390/jcm12216718.

References
1.
Walsh C, Soler N, MALINS J . Diabetes mellitus and primary hyperparathyroidism. Postgrad Med J. 1975; 51(597):446-9. PMC: 2496067. DOI: 10.1136/pgmj.51.597.446. View

2.
Duran C, Sevinc B, Kutlu O, Karahan O . Parathyroidectomy Decreases Insulin Resistance Index in Patients with Primary Hyperparathyroidism. Indian J Surg. 2017; 79(2):101-105. PMC: 5386933. DOI: 10.1007/s12262-015-1431-4. View

3.
Richards M, Thompson N . Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy?. Surgery. 1999; 126(6):1160-6. DOI: 10.1067/msy.2099.101436. View

4.
Luboshitzky R, Chertok-Schaham Y, Lavi I, Ishay A . Cardiovascular risk factors in primary hyperparathyroidism. J Endocrinol Invest. 2009; 32(4):317-21. DOI: 10.1007/BF03345719. View

5.
Hagstrom E, Lundgren E, Rastad J, Hellman P . Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. Eur J Endocrinol. 2006; 155(1):33-9. DOI: 10.1530/eje.1.02173. View